165 related articles for article (PubMed ID: 16382137)
1. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway.
Wan J; Zhang W; Wu L; Bai T; Zhang M; Lo KW; Chui YL; Cui Y; Tao Q; Yamamoto M; Akira S; Wu Z
Mol Cell Biol; 2006 Jan; 26(2):448-56. PubMed ID: 16382137
[TBL] [Abstract][Full Text] [Related]
2. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS
Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861
[TBL] [Abstract][Full Text] [Related]
3. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
Ikeda O; Miyasaka Y; Yoshida R; Mizushima A; Oritani K; Sekine Y; Kuroda M; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2010 Mar; 584(5):865-72. PubMed ID: 20138174
[TBL] [Abstract][Full Text] [Related]
4. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
5. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
6. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1.
Ikeda O; Sekine Y; Mizushima A; Oritani K; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2009 May; 583(10):1567-74. PubMed ID: 19379743
[TBL] [Abstract][Full Text] [Related]
7. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.
Ndour PA; Ouk TS; Brocqueville G; Mougel A; Vanhecke E; Feuillard J; Coll J; Adriaenssens E
Cell Signal; 2010 Feb; 22(2):303-13. PubMed ID: 19796681
[TBL] [Abstract][Full Text] [Related]
9. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
[TBL] [Abstract][Full Text] [Related]
10. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
11. The MYND domain-containing protein BRAM1 inhibits lymphotoxin beta receptor-mediated signaling through affecting receptor oligomerization.
Liu HP; Chung PJ; Liang CL; Chang YS
Cell Signal; 2011 Jan; 23(1):80-8. PubMed ID: 20732415
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1.
Chung PJ; Chang YS; Liang CL; Meng CL
J Biol Chem; 2002 Oct; 277(42):39850-7. PubMed ID: 12181323
[TBL] [Abstract][Full Text] [Related]
13. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.
Uemura N; Kajino T; Sanjo H; Sato S; Akira S; Matsumoto K; Ninomiya-Tsuji J
J Biol Chem; 2006 Mar; 281(12):7863-72. PubMed ID: 16446357
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1.
Wan J; Sun L; Mendoza JW; Chui YL; Huang DP; Chen ZJ; Suzuki N; Suzuki S; Yeh WC; Akira S; Matsumoto K; Liu ZG; Wu Z
Mol Cell Biol; 2004 Jan; 24(1):192-9. PubMed ID: 14673155
[TBL] [Abstract][Full Text] [Related]
15. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
[TBL] [Abstract][Full Text] [Related]
16. RECK is a target of Epstein-Barr virus latent membrane protein 1.
Liu LT; Peng JP; Chang HC; Hung WC
Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450
[TBL] [Abstract][Full Text] [Related]
17. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
Ladendorff NE; Wu S; Lipsick JS
Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
[TBL] [Abstract][Full Text] [Related]
18. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.
Kieser A
Biol Chem; 2008 Oct; 389(10):1261-71. PubMed ID: 18713013
[TBL] [Abstract][Full Text] [Related]
19. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.
Schultheiss U; Püschner S; Kremmer E; Mak TW; Engelmann H; Hammerschmidt W; Kieser A
EMBO J; 2001 Oct; 20(20):5678-91. PubMed ID: 11598011
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.
Zhang X; Sanmun D; Hu L; Fadeel B; Ernberg I
Biochem Biophys Res Commun; 2007 Aug; 360(1):263-8. PubMed ID: 17586463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
